Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bonus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

12 resultados carregados para "patients"
Socioeconomic status shapes treatment timing and duration in arthritis patients
Socioeconomic status shapes treatment timing and duration in arthritis patients
A study initiated by the European Spondyloarthritis Research Collaboration Network (EuroSpA) examined whether patients' countries of residence are associated with the severity of their psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA), when they begin advanced treatmen
Differences in immune cells predict skin cancer treatment outcomes
Differences in immune cells predict skin cancer treatment outcomes
In a first-of-its-kind study by King's College London, researchers have linked changes in two major types of immune cells in blood to different survival outcomes for patients with melanoma.
Genetic variants shed light on kidney transplant rejection
Genetic variants shed light on kidney transplant rejection
Immunosuppressive medications help prevent organ rejection following transplantation, yet some patients still experience rejection despite receiving adequate treatment.
Portable eye exam equipment aims to reduce barriers in rural health care
Portable eye exam equipment aims to reduce barriers in rural health care
Around 75% of American adults need vision correction, but access to eye care remains uneven, particularly in rural communities and for patients with mobility limitations. Destaque: 75%.
The way we talk about physical activity matters in chronic illness
The way we talk about physical activity matters in chronic illness
Many people living with chronic illness say advice about physical activity can feel overwhelming or create feelings of guilt. According to the researchers, the way health care professionals communicate about physical activity may influence whether patients feel more confident abo
Why a doctor saying 'it's normal' can backfire
Why a doctor saying 'it's normal' can backfire
A new study from the University of California San Diego Rady School of Management suggests that when physicians try to reassure patients by saying their symptoms are "normal," patients may infer that treatment isn't necessary—and become less inclined to seek it. Doctors may think
New analysis explains why bone marrow cancer T cells may need therapeutic activation
New analysis explains why bone marrow cancer T cells may need therapeutic activation
A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and Medical Clinic V at Heidelberg University Hospital (UKHD) has characterized T cells in the bone marrow of patients with multiple myeloma and acute myeloid leukemia. The w
Joint fusion surgery reduced walking pain in patients with foot arthritis compared with wa
Joint fusion surgery reduced walking pain in patients with foot arthritis compared with wa
A randomized controlled trial compared first metatarsophalangeal joint (MTPJ) arthrodesis, a joint fusion surgery for painful hallux rigidus (arthritis of the big toe joint), with watchful waiting in reducing walking pain.
Uncovering how Cryptococcus shifts from silent infection to killer fungus
Uncovering how Cryptococcus shifts from silent infection to killer fungus
For most healthy people, Cryptococcus is an unnoticed infection. The immune system walls it off in the lungs and keeps it dormant for life. But in patients undergoing cancer chemotherapy, recovering from an organ transplant, living with HIV or taking newer immunosuppressing drugs
Biomarkers aid cost-benefit analysis of head and neck cancer immunotherapy
Biomarkers aid cost-benefit analysis of head and neck cancer immunotherapy
The cost-effectiveness of the immunotherapy drug pembrolizumab for patients with locally advanced head and neck squamous cell carcinoma may depend on biomarker results, according to a new study.
Real-world study provides new insights into safety of new Alzheimer's drug lecanemab
Real-world study provides new insights into safety of new Alzheimer's drug lecanemab
As new Alzheimer's drugs move from clinical trials into everyday care, families are asking whether these treatments are safe, how long patients can stay on them and whether they truly slow the disease outside tightly controlled studies.
Social prescribing boosts health checks without raising costs
Social prescribing boosts health checks without raising costs
Patients referred to social prescribing are more likely to seek health care in the short term but could end up needing their primary care physician less often within a year, according to a new study by University of Manchester researchers published in eClinicalMedicine.